Clinical

share

Provention Bio announced that it has entered into agreements with Janssen Pharmaceutica NV and Janssen Sciences Ireland UC...

share

Roche announced results from the global phase III ALUR study showing that Alecensa® significantly reduced the risk of...

share

Midatech Pharma has announced the submission of a clinical trial application (CTA) for a first in human study...

share

ViraCyte, LLC, a clinical stage biopharmaceutical company developing cellular immunotherapies for severe infections, announced publication of positive data...

share

Eli Lilly and Company has entered into a settlement agreement with generic companies to resolve pending patent litigation...

share

BioLight Life Sciences announced successful results from its glaucoma insert VS101 (“Eye-D latanoprost insert”) Phase 1/2a clinical trial, which...

share

Brainstorm Cell Therapeutics announced that the California Institute for Regenerative Medicine (CIRM) has awarded Brainstorm a grant of $16 million to support...

share

PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin (plitidepsina), along with other compounds...